Cardio Diagnostics Holdings (CDIO) Non Operating Interest Expenses (2023 - 2026)

Cardio Diagnostics Holdings has disclosed Non Operating Interest Expenses across 4 years of filings, most recently posting $3440.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 26.65% year-over-year to $3440.0; the TTM figure through Jun 2026 stood at $12299.0 (down 24.95% YoY), while the FY2025 annual figure was $14801.0, down 20.6% from the prior year.
• Non Operating Interest Expenses came in at $3440.0 for Q2 2026 at Cardio Diagnostics Holdings, roughly flat from $3439.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $5.0 million in Q1 2023 to a low of $2292.0 in Q4 2025.
• Average Non Operating Interest Expenses over 4 years is $483952.4, with a median of $4690.5 recorded in 2025.
• Year-over-year, Non Operating Interest Expenses plunged 99.88% in 2024 and dropped 19.36% in 2025.
• Over 4 years, Non Operating Interest Expenses stood at $96101.0 in 2023, then plunged by 96.75% to $3127.0 in 2024, then decreased by 26.7% to $2292.0 in 2025, then jumped by 50.09% to $3440.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $3440.0 in Q2 2026, $3439.0 in Q1 2026, and $2292.0 in Q4 2025.